These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 12568498
1. Current and future therapies for airway mucus hypersecretion. Barnes PJ. Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498 [Abstract] [Full Text] [Related]
3. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases. Disse B. Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499 [Abstract] [Full Text] [Related]
5. Physiology of airway mucus secretion and pathophysiology of hypersecretion. Rogers DF. Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382 [Abstract] [Full Text] [Related]
6. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. Lai H, Rogers DF. J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774 [Abstract] [Full Text] [Related]
7. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Simpson JL, Phipps S, Gibson PG. Pharmacol Ther; 2009 Oct; 124(1):86-95. PubMed ID: 19555716 [Abstract] [Full Text] [Related]
8. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy. Lai HY, Rogers DF. Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):67-76. PubMed ID: 19907312 [Abstract] [Full Text] [Related]
9. Agents against cytokine synthesis or receptors. Yamagata T, Ichinose M. Eur J Pharmacol; 2006 Mar 08; 533(1-3):289-301. PubMed ID: 16457805 [Abstract] [Full Text] [Related]
10. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Catley MC, Sukkar MB, Chung KF, Jaffee B, Liao SM, Coyle AJ, Haddad el-B, Barnes PJ, Newton R. Mol Pharmacol; 2006 Aug 08; 70(2):697-705. PubMed ID: 16687566 [Abstract] [Full Text] [Related]
11. Airway mucus hypersecretion in asthma: an undervalued pathology? Rogers DF. Curr Opin Pharmacol; 2004 Jun 08; 4(3):241-50. PubMed ID: 15140415 [Abstract] [Full Text] [Related]
12. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options. Rogers DF. COPD; 2005 Sep 08; 2(3):341-53. PubMed ID: 17146999 [Abstract] [Full Text] [Related]
13. Extending the understanding of sensory neuropeptides. De Swert KO, Joos GF. Eur J Pharmacol; 2006 Mar 08; 533(1-3):171-81. PubMed ID: 16464447 [Abstract] [Full Text] [Related]
14. Epidemiological studies in mucus hypersecretion. Vestbo J. Novartis Found Symp; 2002 Mar 08; 248():3-12; discussion 12-9, 277-82. PubMed ID: 12568485 [Abstract] [Full Text] [Related]
15. Emerging mucus regulating drugs in inflammatory and allergic lung disease. Hauber HP, Zabel P. Inflamm Allergy Drug Targets; 2008 Mar 08; 7(1):30-4. PubMed ID: 18473898 [Abstract] [Full Text] [Related]
16. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease. Malerba M, Radaeli A, Mancuso S, Polosa R. J Biol Regul Homeost Agents; 2010 Mar 08; 24(2):123-30. PubMed ID: 20487625 [Abstract] [Full Text] [Related]